Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 48, 102694
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
- Novartis
- Biogen
- Merck KGaA
- Hjärnfonden
This publication has 18 references indexed in Scilit:
- Multiple sclerosis—a quiet revolutionNature Reviews Neurology, 2015
- Pregnancy outcomes in patients exposed to interferon beta-1b: Table 1Journal of Neurology, Neurosurgery & Psychiatry, 2014
- Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse eventsBMJ Open, 2014
- Multiple sclerosis and pregnancy: experience from a nationwide database in GermanyTherapeutic Advances in Neurological Disorders, 2012
- Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapyMultiple Sclerosis Journal, 2011
- Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosisNeurology, 2010
- Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational studyMultiple Sclerosis Journal, 2009
- Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?Journal of Neurology, 2008
- The Association Between Major Birth Defects and Preterm BirthMaternal and Child Health Journal, 2008
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006